Variant report
Variant | esv3343122 |
---|---|
Chromosome Location | chr11:55336626-55338574 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFF | chr11:55337936-55337977 | HepG2 | liver: | n/a | chr11:55337957-55337975 |
2 | MAFK | chr11:55337914-55337972 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:55338135-55338185 | Caco-2 | colon: | n/a |
2 | chr11:55338135-55338185 | GM12878 | blood: | n/a |
3 | chr11:55338135-55338185 | MCF-7 | breast: | n/a |
4 | chr11:55338135-55338185 | NH-A | brain: | n/a |
5 | chr11:55338135-55338185 | K562 | blood: | n/a |
6 | chr11:55338135-55338185 | BJ | skin: | n/a |
7 | chr11:55338135-55338185 | HRPEpiC | eye: | n/a |
8 | chr11:55338135-55338185 | ECC-1 | luminal epithelium: | n/a |
9 | chr11:55338135-55338185 | HCM | heart: | n/a |
10 | chr11:55338135-55338185 | AG04449 | skin: | fetal |
11 | chr11:55338135-55338185 | HIPEpiC | eye: | n/a |
12 | chr11:55338135-55338185 | HPAEpiC | pulmonary alveolar: | n/a |
13 | chr11:55338135-55338185 | H1-hESC | embryonic stem cell: | embryo |
14 | chr11:55338135-55338185 | ovcar-3 | ovarian: | n/a |
15 | chr11:55338135-55338185 | AG04450 | lung: | fetal |
16 | chr11:55338135-55338185 | HMEC | breast: | n/a |
17 | chr11:55338135-55338185 | A549 | lung: | n/a |
18 | chr11:55338135-55338185 | Jurkat | blood: | n/a |
19 | chr11:55338135-55338185 | PFSK-1 | brain: | n/a |
20 | chr11:55338135-55338185 | GM19239 | blood: | n/a |
21 | chr11:55338135-55338185 | HRE | kidney: | n/a |
22 | chr11:55338135-55338185 | IMR90 | lung: | fetal |
23 | chr11:55338135-55338185 | Hepatocyte | liver: | n/a |
24 | chr11:55338135-55338185 | AG09309 | skin: | n/a |
25 | chr11:55338135-55338185 | SAEC | small airway: | n/a |
26 | chr11:55338135-55338185 | HEEpiC | esophagus: | n/a |
27 | chr11:55338135-55338185 | HepG2 | liver: | n/a |
28 | chr11:55338135-55338185 | BE2_C | brain: | n/a |
29 | chr11:55338135-55338185 | HCPEpiC | choroid plexus: | n/a |
30 | chr11:55338135-55338185 | ProgFib | skin: | n/a |
31 | chr11:55338135-55338185 | SK-N-SH | brain: | n/a |
32 | chr11:55338135-55338185 | SKMC | muscle: | n/a |
33 | chr11:55338135-55338185 | SK-N-MC | brain: | n/a |
34 | chr11:55338135-55338185 | HNPCEpiC | eye: | n/a |
35 | chr11:55338135-55338185 | SK-N-SH_RA | brain: | n/a |
36 | chr11:55338135-55338185 | HEK293 | kidney: | embryo |
37 | chr11:55338135-55338185 | AG10803 | skin: | n/a |
38 | chr11:55338135-55338185 | PrEC | prostate: | n/a |
39 | chr11:55338135-55338185 | Hela-S3 | cervix: | n/a |
40 | chr11:55338135-55338185 | GM12892 | blood: | n/a |
41 | chr11:55338135-55338185 | U87 | brain: | n/a |
42 | chr11:55338135-55338185 | NHBE | bronchial: | n/a |
43 | chr11:55338135-55338185 | GM12891 | blood: | n/a |
44 | chr11:55338135-55338185 | NT2-D1 | testis: | n/a |
45 | chr11:55338135-55338185 | HCT-116 | colon: | n/a |
46 | chr11:55338135-55338185 | RPTEC | kidney: | n/a |
47 | chr11:55338135-55338185 | HCF | heart: | n/a |
48 | chr11:55338135-55338185 | LNCaP | prostate: | n/a |
49 | chr11:55338135-55338185 | MCF10A-Er-Src | breast: | n/a |
50 | chr11:55338135-55338185 | PANC-1 | pancreas: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR4C16 | TF binding region |
OR4C16 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577758992 | chr11:55337802-55337803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535153477 | chr11:55337807-55337808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536892132 | chr11:55337809-55337810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75409911 | chr11:55337841-55337842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138785960 | chr11:55337844-55337845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77853930 | chr11:55337862-55337863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554914272 | chr11:55337868-55337869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533435656 | chr11:55337870-55337871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192212867 | chr11:55337873-55337874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183693240 | chr11:55337916-55337917 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs567204424 | chr11:55337921-55337922 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs564899899 | chr11:55337923-55337924 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs576846365 | chr11:55337981-55337982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138705711 | chr11:55337996-55337997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs484860 | chr11:55338008-55338009 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs11230173 | chr11:55338029-55338030 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs530317375 | chr11:55338082-55338083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61916565 | chr11:55338095-55338096 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs563636727 | chr11:55338107-55338108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531138098 | chr11:55338127-55338128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140500769 | chr11:55338130-55338131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs367905007 | chr11:55338136-55338137 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs570528698 | chr11:55338143-55338144 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs528552380 | chr11:55338162-55338163 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs547076705 | chr11:55338164-55338165 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs371821537 | chr11:55338171-55338172 | Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs537553265 | chr11:55338196-55338197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565698407 | chr11:55338197-55338198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74521312 | chr11:55338227-55338228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554849684 | chr11:55338236-55338237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569941920 | chr11:55338241-55338242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190325918 | chr11:55338328-55338329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554286122 | chr11:55338347-55338348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574192724 | chr11:55338359-55338360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558551852 | chr11:55338369-55338370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182925830 | chr11:55338383-55338384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145617455 | chr11:55338384-55338385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs117355805 | chr11:55338395-55338396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21990379 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:55337800-55338200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr11:55338000-55338400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |